Folic acid versus folinic acid during methotrexate treatment for low-risk gestational trophoblastic neoplasia
Replacement of folinic acid with folic acid in low-risk GTN patients to reduce the toxicity that may develop associated with MTX treatment resulted in similar treatment success rates. Still, no significant change was observed regarding toxicity and resistance. There is a need for comprehensive prospective studies to further elucidate this relationship.
Authors
- Gökhan Bolluk (ORCID: https://orcid.org/0000-0002-3506-6806)
- Sedat Akgöl (ORCID: https://orcid.org/0000-0001-8609-3049)
- Behzat Can (ORCID: https://orcid.org/0000-0002-3797-8227)
- Adnan Budak (ORCID: https://orcid.org/0000-0003-4145-3973)
- Özgür Akbayır (ORCID: https://orcid.org/0000-0002-2699-4969)
- Emine Zeynep Yılmaz (ORCID: https://orcid.org/0000-0002-3537-8340)
- Şeyhmus Tunç (ORCID: https://orcid.org/0000-0002-7095-9482)
- Süleyman Cemil Oğlak (ORCID: https://orcid.org/0000-0001-7634-3008)
- Mehmet Şükrü Budak (ORCID: https://orcid.org/0000-0001-7328-4188)
- Mesut Ali Halisçelik (ORCID: https://orcid.org/0000-0003-1100-0113)
- Kevser Arkan (ORCID: https://orcid.org/0009-0007-5300-6536)
- Ali Deniz Erkmen (ORCID: https://orcid.org/0009-0004-2137-2986)
Institutions
- Istanbul Metropolitan Municipality (TR)
- Memorial Sisli Hospital (TR)
- Sağlık Bilimleri Üniversitesi (TR)
- Universidad CES (CO)
- Diyarbakır Gazi Yaşargil Eğitim ve Araştırma Hastanesi (TR)
Publication Details
- Journal
- Ginekologia Polska
- Published
- 2025-02-04
- DOI
- https://doi.org/10.5603/gpl.101142
- Citations
- 1
- Primary Topic
- Gestational Trophoblastic Disease Studies
- Type
- article
- Field-Weighted Citation Impact
- 1.88